Odyssey Therapeutics, Inc. (ODTX) Financial Statements

11 Followers

Odyssey Therapeutics, Inc. Financial Overview

Odyssey Therapeutics, Inc.'s market cap is currently $996.25M. The company's EPS TTM is $; its P/E ratio is -3.85; Odyssey Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25
Income Statement
Total Revenue	$ 2.98M
Gross Profit	$ 2.98M
Operating Income	$ -161.16M
EBITDA	$ -144.65M
Net Income	$ -148.65M
Balance Sheet
Cash & Short-Term Investments	$ 181.36M
Total Assets	$ 269.79M
Total Debt	$ 27.11M
Net Debt	$ -14.58M
Total Liabilities	$ 758.07M
Stockholders' Equity	$ -488.28M
Cash Flow
Free Cash Flow	$ -130.70M
Operating Cash Flow	$ -129.47M
Investing Cash Flow	$ -103.94M
Financing Cash Flow	$ 215.65M

Currency in USD

Odyssey Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Odyssey Therapeutics, Inc. Debt to Assets

Balance Sheet >

Odyssey Therapeutics, Inc. Cash Flow

Cash Flow >

Odyssey Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >